Testing effectiveness (Phase 2)UnknownNCT03848611What this trial is testingCM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).Who this might be right forNon-small Cell Lung Cancer AnewPharma 20
Large-scale testing (Phase 3)Temporarily pausedNCT03777579What this trial is testingFirst-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBCWho this might be right forTriple Negative Breast Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 375
Not applicableUnknownNCT04116918What this trial is testingEfficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLCWho this might be right forNSCLC Stage IVEGFR T790M-negativeAnlotinib+1 more Baodong Qin 100
Large-scale testing (Phase 3)Study completedNCT04085276What this trial is testingToripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic TreatmentWho this might be right forTriple-Negative Breast Cancer Shanghai Junshi Bioscience Co., Ltd. 531
Testing effectiveness (Phase 2)UnknownNCT03946917What this trial is testingJS001 Combined With Regorafenib in Patients With Advanced Colorectal CancerWho this might be right forColorectal Cancer Sun Yat-sen University 44
Testing effectiveness (Phase 2)UnknownNCT03811379What this trial is testingToripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyWho this might be right forSmall Cell Carcinoma of EsophagusAdvanced Cancer Sun Yat-sen University 43
Testing effectiveness (Phase 2)UnknownNCT03941795What this trial is testingPhase II Study in the Treatment of Patients With Advanced Mucinous MelanomaWho this might be right forAdvanced Mucosal Melanoma Peking University Cancer Hospital & Institute 99
Large-scale testing (Phase 3)Active Not RecruitingNCT04523493What this trial is testingPhase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCCWho this might be right forAdvanced Hepatocellular Carcinoma (HCC) Shanghai Junshi Bioscience Co., Ltd. 530
Testing effectiveness (Phase 2)UnknownNCT04527068What this trial is testingQL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal CancerWho this might be right forRefractory Metastatic Colorectal CancerpMMRMSS Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Large-scale testing (Phase 3)Study completedNCT03856411What this trial is testingEvaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLCWho this might be right forTreatment-naive Advanced Non-small Cell Lung Cancer Shanghai Junshi Bioscience Co., Ltd. 465
Testing effectiveness (Phase 2)Active Not RecruitingNCT05522985What this trial is testingToripalimab-based Neoadjuvant Therapy in LA-HNSCCWho this might be right forHead and Neck Squamous Cell CarcinomaNeoadjuvant Chemotherapy Tianjin Medical University Cancer Institute and Hospital 122
Testing effectiveness (Phase 2)UnknownNCT03602547What this trial is testingStudy of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.Who this might be right forMucosal Melanoma AnewPharma 40
Early research (Phase 1)WithdrawnNCT05262842What this trial is testingJS001+IMP4297 in Patients With Advanced CancerWho this might be right forAdvanced Cancer Shanghai Junshi Bioscience Co., Ltd.
Large-scale testing (Phase 3)Active Not RecruitingNCT03859128What this trial is testingToripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical ResectionWho this might be right forHepatocellular Carcinoma Shanghai Junshi Bioscience Co., Ltd. 427
Testing effectiveness (Phase 2)Looking for participantsNCT05917158What this trial is testingRC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial CarcinomaWho this might be right forCarcinomaUpper Tract Urothelial CarcinomaUTUC Jinling Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT03581786What this trial is testingThe Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal CancerWho this might be right forRecurrent or Metastatic NPC Shanghai Junshi Bioscience Co., Ltd. 289
Testing effectiveness (Phase 2)Looking for participantsNCT05033392What this trial is testingPD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction CancerWho this might be right forStomach Neoplasms Wan He 62
Testing effectiveness (Phase 2)Looking for participantsNCT06623136What this trial is testingES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Elpiscience (Suzhou) Biopharma, Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT04523883What this trial is testingConcurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT)Who this might be right forHead and Neck Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 316
Large-scale testing (Phase 3)WithdrawnNCT04568304What this trial is testingA Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial CarcinomaWho this might be right forLocally Advanced or Metastatic Urothelial Carcinoma Shanghai Junshi Bioscience Co., Ltd.